Ticker
IGCCompany Name
IGC PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -3.79M | -285.61% | $ 1.33M |
3/31/2025 | $ -4.87M | -382.93% | $ 1.27M |
12/31/2024 | $ -4.68M | -378.8% | $ 1.24M |
9/30/2024 | $ -4.99M | -422.06% | $ 1.18M |
6/30/2024 | $ -5.64M | -530.89% | $ 1.06M |
3/31/2024 | $ -5.29M | -393.53% | $ 1.34M |
12/31/2023 | $ -6.28M | -516.61% | $ 1.22M |
9/30/2023 | $ -6.31M | -469.72% | $ 1.34M |
6/30/2023 | $ -5.94M | -473.39% | $ 1.25M |
3/31/2023 | $ -6.82M | -748.52% | $ 911K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for IGC PHARMA INC is calculated as follows: FCF [ $ -14.25M ] / Revenues [ $ 1.31M ]
(=) FCF % [ -1087.11% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |